Innovating Works

PGK

Desconocido
SYSMALVAC: Identifying correlates of protection to accelerate vaccine trials systems evaluation of two models... Vaccine development is an empirical process (trial and error) and involves a long, expensive clinical development pipeline to license an eff...
Financiado
IBDASE: Mucosal protease and their inhibitors in inflammatory bowel disease From etiopathogenetic insight t... PROGENIKA BIOPHARMA SA participó en un FP7 IBDase addresses the etiology and pathogenesis of inflammatory bowel disease (IBD) with a multidisciplinary plan for innovative diagnosis an...
Financiado
HYPORTH: New approaches in the development of Hypoallergenic implant material in Orthopaedics steps to perso... PROGENIKA BIOPHARMA SA participó en un FP7 Europe is confronted by a demographic challenge as a decreasing work force has to support an increasing elderly population. The economic ris...
Financiado
BEST MS: Best EScalation Treatment in Multiple Sclerosis MS PROGENIKA BIOPHARMA SA participó en un FP7 "Multiple Sclerosis (MS) is a devastating disease of the central nervous system affecting 2.5 million worldwide. MS is a field of constant t...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.